Bryan Newman

Company: US Food & Drug Administration (FDA)

Job title: Lead Pharmacologist


Challenges & Considerations for the Transition to Low Global Warming Potential (LGWP) Propellants with Metered Dose Inhalers 9:45 am

Discussing the scientific understanding of propellants and their impact on MDI performance Overview of the previous PFC to HFA propellant transition and lessons learned Understanding the current LGWP propellant transition and the potential challenges and considerations this may present for MDI developersRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.